Mastrapasqua Asset Management Inc Biogen Inc. Transaction History

Mastrapasqua Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 12, 2019	SELL	$219.29 - $241.72 $3.73 Million - $4.11 Million	-17,015 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $9,318 - $14,575	43 Added 0.25%	17,015 $4.02 Million
Q4 2018 Feb 12, 2019	SELL	$278.5 - $352.75 $354,252 - $448,698	-1,272 Reduced 6.97%	16,972 $5.11 Million
Q3 2018 Nov 15, 2018	BUY	$293.51 - $383.83 $5.35 Million - $7 Million	18,244 New	18,244 $6.45 Million

998

130M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Mastrapasqua Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Mastrapasqua Asset Management Inc with notifications on news.